DiscoverThe Lancet in conversation withMichael Heneka on passive anti-amyloid β immunotherapy in Alzheimer’s disease
Michael Heneka on passive anti-amyloid β immunotherapy in Alzheimer’s disease

Michael Heneka on passive anti-amyloid β immunotherapy in Alzheimer’s disease

Update: 2025-01-09
Share

Description

Michael Heneka joins Chloe Wilson and Bea Gomez Perez-Nievas of The Lancet to discuss a therapeutics paper discussing the opportunities and challenges of passive anti-amyloid β immunotherapy in Alzheimer's disease.

Read the full article:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01883-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
In Channel
ASCO 2025 Debrief

ASCO 2025 Debrief

2025-06-1115:14

Previewing ASCO 2025

Previewing ASCO 2025

2025-05-3005:24

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Michael Heneka on passive anti-amyloid β immunotherapy in Alzheimer’s disease

Michael Heneka on passive anti-amyloid β immunotherapy in Alzheimer’s disease

The Lancet Group